Nivolumab + relatlimab for the treatment of unresectable or metastatic melanoma
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2023.2215922
Abstract: ABSTRACT Introduction Though melanoma is one of the less common skin malignancies, it accounts for the majority of deaths due to cutaneous cancers. The recent progress and drug approvals in targeted treatment and immunotherapy revolutionized… read more here.
Keywords: nivolumab relatlimab; melanoma; combination; relatlimab treatment ... See more keywords